|
Clinical Information
|
patient
|
XJ202025 |
|
Age
|
52 |
|
Gender
|
M |
|
Genotype
|
HBV_gtC |
|
Diagnosis
|
hepatocellular carcinoma |
|
HBV DNA
|
618000IU/ml |
|
HBeAg
|
1 |
|
AFP(ng/ml)
|
>1210 |
|
PLT(log IU/mL)
|
64 |
|
HBcAb
|
1 |
|
HBsAb
|
0 |
|
HBeAb
|
0 |
|
HBsAg
|
1 |
|
ctDNA concentration
|
0.04998 |
|
marker
|
ctDNA- |
|
Hospital
|
Eastern Hepatobiliary Surgery Hospital, Shanghai |
|
HBsAg (IU/ml)
|
>250 |
|
BCLC
|
C |
|
ACJJ
|
II |
|
Tumor maximum size
|
9 |
|
Tumor count
|
1 |
|
MVI
|
M1 |
|
AFP-L3
|
31.6 |
|
PIVKA-II (mAU/ml)
|
14014 |
|
CA199 (U/ml)
|
106 |
|
Cirrhosis history
|
1 |
|
Fatty liver
|
0 |
|
Hepatic encephalopathy (1-3)
|
1 |
|
Ascites (1-3)
|
1 |
|
TBIL (μmol/L)
|
1 |
|
ALB (g/L)
|
1 |
|
INR
|
1 |
|
Score
|
5 |
|
Child-Pugh stage
|
A |
|
HBV integration detection
|
Yes |
|
Integration number
|
22 |
|
HBV subtype frequency
|
0.987740806 |
|
|
Virus Dataset Sample Detail